LEONHARDT HARRY J

CIK 00012861024 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001286102

Recent Transactions

50 trades

Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−111,700→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−72,568→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−137,000→ 0 total
Disposition from Tender
Poseida Therapeutics, Inc.
Common Stock
2025-01-08−223,640→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−125,283→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−160,385→ 0 total
Award
Poseida Therapeutics, Inc.
Common Stock
2024-03-01+80,743→ 230,946 total
Tax Payment
Poseida Therapeutics, Inc.
Common Stock
2024-03-01$4.13/sh−16,306→ 214,640 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2024-03-01+111,700→ 111,700 total
Tax Payment
Poseida Therapeutics, Inc.
Common Stock
2023-03-01$5.35/sh−4,323→ 144,203 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2023-03-01+125,283→ 125,283 total
Award
Poseida Therapeutics, Inc.
Common Stock
2023-03-01+92,772→ 148,526 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2022-03-01+72,568→ 72,568 total
Award
Poseida Therapeutics, Inc.
Common Stock
2022-03-01+50,000→ 50,000 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-02-04+137,000→ 137,000 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2019-04-13+6,875→ 68,750 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2019-04-13$16.54/sh−2,377→ 66,373 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2019-04-13−6,875→ 0 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2019-02-22+11,392→ 65,814 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2019-02-22−11,392→ 22,784 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2019-02-22$16.81/sh−3,939→ 61,875 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2019-02-14$16.54/sh−2,700→ 54,422 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2019-02-14+7,809→ 57,122 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2019-02-14−7,809→ 23,425 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2019-02-12+71,602→ 71,602 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2019-02-12+37,538→ 37,538 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2019-02-03−15,413→ 15,413 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2019-02-03+15,413→ 54,971 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2019-02-03$16.12/sh−5,658→ 49,313 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2018-04-13+6,875→ 41,935 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2018-04-13−6,875→ 6,875 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2018-04-13$19.37/sh−2,377→ 39,558 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2018-02-22+11,392→ 38,999 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2018-02-22−11,392→ 34,176 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2018-02-22$19.28/sh−3,939→ 35,060 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2018-02-14+54,780→ 54,780 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2018-02-14+31,234→ 31,234 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2018-02-03$18.37/sh−5,605→ 27,607 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2018-02-03+15,413→ 33,212 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2018-02-03−15,413→ 30,826 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2017-04-13+6,875→ 20,382 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2017-04-13−6,875→ 13,750 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2017-04-13$12.81/sh−2,583→ 17,799 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2017-02-22+45,568→ 45,568 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2017-02-22+72,925→ 72,925 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2017-02-03$12.26/sh−6,198→ 13,507 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2017-02-03+15,413→ 19,705 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2017-02-03−15,413→ 46,239 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2016-04-13+6,875→ 6,875 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2016-04-13$11.76/sh−2,583→ 4,292 total

Companies

Recent Filings

Address

9360 TOWNE CENTRE DR

SAN DIEGO, CA, 92121

View on SEC.gov